MoneyWorks4Me

Trident Lifeline - Quaterly Results

22 Jan 2025 Evaluate
The total revenue surged to Rs. 165.09 millions, up 132.85% for the December 2024 quarter as against Rs. 70.90 millions during the year-ago period.Net Profit for the quarter ended December 2024 zoomed to 173.44% from Rs. 11.07 millions to Rs. 30.27  millions.The company reported a good operating profit of 46.77 millions compared to 17.31 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 165.09 70.90 132.85 469.07 256.66 82.76 446.52 316.92 40.89
Other Income 5.39 2.50 115.60 15.29 9.58 59.60 22.03 11.54 90.90
PBIDT 46.77 17.31 170.19 141.68 63.94 121.58 110.33 74.04 49.01
Interest 3.51 1.46 140.41 8.20 3.50 134.29 4.63 4.66 -0.64
PBDT 43.26 15.85 172.93 133.48 60.44 120.85 105.70 69.38 52.35
Depreciation 3.79 1.93 96.37 8.62 4.87 77.00 7.70 3.65 110.96
PBT 39.47 13.92 183.55 124.86 55.57 124.69 98.00 65.73 49.09
TAX 9.20 2.85 222.81 30.55 13.42 127.65 27.56 5.61 391.27
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 3.71 5.19 -28.52
PAT 30.27 11.07 173.44 94.31 42.15 123.75 70.44 60.12 17.17
Equity 114.99 114.99 0.00 114.99 114.99 0.00 114.99 114.99 0.00
PBIDTM(%) 28.33 24.41 16.04 30.20 24.91 21.24 24.71 23.36 5.76
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..